{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:14:26Z","timestamp":1794003266832,"version":"4.8.0"},"reference-count":137,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH\/NIDCR","award":["R56DE025393"],"award-info":[{"award-number":["R56DE025393"]}]},{"name":"NIH\/NIDCR","award":["R01DE025393"],"award-info":[{"award-number":["R01DE025393"]}]},{"name":"NIH\/NIDCR","award":["R01DE029694"],"award-info":[{"award-number":["R01DE029694"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Gene therapy has emerged as a promising therapeutic approach across various oral diseases. This review examines current applications and future prospects of gene therapy in dentistry, focusing on five key areas: oral cancer, cancer-related pain, xerostomia (dry mouth), dental caries, and periodontal disease. Recent advances in viral and non-viral vectors have enabled more efficient gene delivery systems, with particular success in cancer pain management through \u00b5-opioid receptor gene transfer and xerostomia treatment using aquaporin-1 gene therapy. For periodontal applications, gene therapy strategies include both immunomodulation and tissue regeneration approaches using growth factors like platelet-derived growth factor and bone morphogenetic proteins. While significant progress has been made, particularly in treating radiation-induced xerostomia and oral cancer pain, challenges remain in vector optimization and delivery methods. Clinical trials, predominantly in Phase I, indicate both the potential and current limitations of gene therapy in oral healthcare. This review synthesizes current evidence and outlines future directions for gene therapy applications in oral medicine and dentistry.<\/jats:p>","DOI":"10.3390\/pharmaceutics17070859","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T06:46:12Z","timestamp":1751438772000},"page":"859","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Application of Gene Therapy to Oral Diseases"],"prefix":"10.3390","volume":"17","author":[{"given":"Seiichi","family":"Yamano","sequence":"first","affiliation":[{"name":"Department of Prosthodontics, New York University College of Dentistry, New York, NY 10010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3946-9538","authenticated-orcid":false,"given":"Kenji","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Prosthodontics, New York University College of Dentistry, New York, NY 10010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichiro","family":"Taguchi","sequence":"additional","affiliation":[{"name":"Department of Operative Dentistry, Endodontology and Periodontology, Matsumoto Dental University, Shiojiri-shi 399-0704, Nagano, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.270.5235.475","article-title":"T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years","volume":"270","author":"Blaese","year":"1995","journal-title":"Science"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1126\/science.286.5448.2244","article-title":"Gene therapy death prompts review of adenovirus vector","volume":"286","author":"Marshall","year":"1999","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1474-4422(21)00001-6","article-title":"Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy","volume":"20","author":"Day","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.ymthe.2020.06.001","article-title":"Long-term follow-up of AAV for gene transfer: AAV2-hFIX16 for severe hemophilia B","volume":"28","author":"George","year":"2020","journal-title":"Mol. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/mt.2010.135","article-title":"A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson\u2019s disease","volume":"18","author":"Muramatsu","year":"2010","journal-title":"Mol. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(19)31146-8","article-title":"Oral diseases: A global public health challenge","volume":"394","author":"Peres","year":"2019","journal-title":"Lancet"},{"key":"ref_7","unstructured":"Jin, S., Zhu, M., Yan, J., Fang, X., Zhang, H., and Shi, J. (2022). Gene therapy for periodontal tissue engineering: Current approaches and future perspectives. Front. Genet., 13."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hirakawa, M.P., Krishnakumar, R., Timlin, J.A., Carney, J.P., and Butler, K.S. (2020). Gene editing and CRISPR in the clinic: Current and future perspectives. Biosci. Rep., 40.","DOI":"10.1042\/BSR20200127"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Nayerossadat, N., Maedeh, T., and Ali, P.A. (2012). Viral and nonviral delivery systems for gene delivery. Adv. Biomed. Res., 1.","DOI":"10.4103\/2277-9175.98152"},{"key":"ref_11","unstructured":"Wiley Database (2025, April 11). Gene Therapy Clinical Trials Worldwide. Available online: https:\/\/www.genetherapynet.com\/clinical-trials.html."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2165\/00003495-200060020-00002","article-title":"Viral vectors for gene transfer: A review of their use in the treatment of human diseases","volume":"60","author":"Walther","year":"2000","journal-title":"Drugs"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-bioeng-071813-104938","article-title":"Viral vectors for gene therapy: Translational and clinical outlook","volume":"17","author":"Kotterman","year":"2015","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"19403","DOI":"10.1073\/pnas.1210662109","article-title":"Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction","volume":"109","author":"Baum","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/gt.2016.87","article-title":"Late responses to adenoviral-mediated transfer of the aquaporin-1 gene for radiation-induced salivary hypofunction","volume":"24","author":"Alevizos","year":"2016","journal-title":"Gene Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev-virology-092818-015530","article-title":"Recombinant adeno-associated virus gene therapy in light of Luxturna (and Zolgensma and Glybera): Where are we, and how did we get here?","volume":"6","author":"Keeler","year":"2019","journal-title":"Annu. Rev. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1073\/pnas.1601992113","article-title":"Aquaporin gene therapy corrects Sj\u00f6gren\u2019s syndrome phenotype in mice","volume":"113","author":"Lai","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","first-page":"629","article-title":"Advances in salivary gland gene therapy-from bench to bedside","volume":"22","author":"Lombaert","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Basile","year":"2000","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Lundstrom, K. (2018). Viral vectors in gene therapy. Diseases, 6.","DOI":"10.3390\/diseases6020042"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/cas.13027","article-title":"Oncolytic virus therapy: A new era of cancer treatment at dawn","volume":"107","author":"Fukuhara","year":"2016","journal-title":"Cancer Sci."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Haddad, D. (2017). Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery. Front. Oncol., 7.","DOI":"10.3389\/fonc.2017.00096"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.biomaterials.2013.11.012","article-title":"Long-term efficient gene delivery using polyethylenimine with modified Tat peptide","volume":"35","author":"Yamano","year":"2014","journal-title":"Biomaterials"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/gt.2017.5","article-title":"Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems","volume":"24","author":"Guan","year":"2017","journal-title":"Gene Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s10529-014-1497-2","article-title":"Efficient in vivo gene delivery using modified Tat peptide with cationic lipids","volume":"36","author":"Yamano","year":"2014","journal-title":"Biotechnol. Lett."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kasai, H., Inoue, K., Imamura, K., Yuvienco, C., Montclare, J.K., and Yamano, S. (2019). Efficient siRNA delivery and gene silencing using a lipopolypeptide hybrid vector mediated by a caveolae-mediated and temperature-dependent endocytic pathway. J. Nanobiotechnology, 17.","DOI":"10.1186\/s12951-019-0444-8"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jconrel.2011.02.004","article-title":"Modified Tat peptide with cationic lipids enhances gene transfection efficiency via temperature-dependent and caveolae-mediated endocytosis","volume":"152","author":"Yamano","year":"2011","journal-title":"J. Control. Release"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/00016357.2017.1292427","article-title":"Effect of local hIL-10 gene therapy on experimental periodontitis in ovariectomized rats","volume":"75","author":"Li","year":"2017","journal-title":"Acta Odontol. Scand."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nature19764","article-title":"In vitro and ex vivo strategies for intracellular delivery","volume":"538","author":"Stewart","year":"2016","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e20240020","DOI":"10.1002\/SMMD.20240020","article-title":"Developing functional hydrogels for treatment of oral diseases","volume":"3","author":"Song","year":"2024","journal-title":"Smart Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Bo, Y., Yang, L., Liu, B., Tian, G., Li, C., Zhang, L., Sang, X., Wang, L., Li, Y., and Chen, Z. (2022). Exosomes from human induced pluripotent stem cells-derived keratinocytes accelerate burn wound healing. J. Nanobiotechnology, 20.","DOI":"10.1186\/s12951-022-01504-8"},{"key":"ref_35","first-page":"GE01","article-title":"Non viral vectors in gene therapy- an overview","volume":"9","author":"Ramamoorth","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMra1706910","article-title":"Gene therapy","volume":"381","author":"High","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1067\/mpr.2001.113778","article-title":"A review of saliva: Normal composition, flow, and function","volume":"85","author":"Humphrey","year":"2001","journal-title":"J. Prosthet. Dent."},{"key":"ref_38","first-page":"381","article-title":"Early insights from commercialization of gene therapies","volume":"35","author":"Touchot","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/pgmj.2007.061994","article-title":"Gene therapy in head and neck cancer: A review","volume":"83","author":"Chisholm","year":"2007","journal-title":"Postgrad. Med. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/107327480200900502","article-title":"Molecular genetics of head and neck cancer","volume":"9","author":"Gleich","year":"2002","journal-title":"Cancer Control"},{"key":"ref_41","first-page":"187","article-title":"Therapeutic siRNA: Principles, challenges, and strategies","volume":"85","author":"Gavrilov","year":"2012","journal-title":"Yale J. Biol. Med."},{"key":"ref_42","first-page":"20210146","article-title":"Recent advances in mRNA delivery systems for the treatment of oral and maxillofacial diseases","volume":"3","author":"Zhang","year":"2023","journal-title":"Exploration"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/j.pain.0000000000000750","article-title":"Ex vivo nonviral gene delivery of \u03bc-opioid receptor to attenuate cancer-induced pain","volume":"158","author":"Yamano","year":"2017","journal-title":"Pain"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12990-015-0018-1","article-title":"Current gene therapy using viral vectors for chronic pain","volume":"11","author":"Guedon","year":"2015","journal-title":"Mol. Pain"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/mt.2010.19","article-title":"Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons","volume":"18","author":"Mason","year":"2010","journal-title":"Mol. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/gt.2016.73","article-title":"Effect of sustained PDGF nonviral gene delivery on repair of tooth-supporting bone defects","volume":"24","author":"Plonka","year":"2017","journal-title":"Gene Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.archoralbio.2016.11.013","article-title":"Transfer of the bone morphogenetic protein 4 gene into rat periodontal ligament by in vivo electroporation","volume":"74","author":"Tsuchiya","year":"2017","journal-title":"Arch. Oral Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1902\/jop.2017.170328","article-title":"Non-surgical model for alveolar bone regeneration by bone morphogenetic protein-2\/7 gene therapy","volume":"89","author":"Kawai","year":"2018","journal-title":"J. Periodontol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"72676","DOI":"10.18632\/oncotarget.20243","article-title":"Inhibiting PHD2 in bone marrow mesenchymal stem cells via lentiviral vector-mediated RNA interference facilitates the repair of periodontal tissue defects in SD rats","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"ref_50","first-page":"7","article-title":"Human \u03b2-defensin-2 gene transduction of dental pulp cells: A model for pulp antimicrobial gene therapy","volume":"29","author":"Huang","year":"2004","journal-title":"Int. J. Oral Biol."},{"key":"ref_51","first-page":"3328","article-title":"The recent advances in scaffolds for integrated periodontal regeneration","volume":"6","author":"Woo","year":"2021","journal-title":"Bioact. Mater."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1128\/iai.61.10.4375-4381.1993","article-title":"Expression and secretion of an Arthrobacter dextranase in the oral bacterium Streptococcus gordonii","volume":"61","author":"Kubo","year":"1993","journal-title":"Infect. Immun."},{"key":"ref_53","first-page":"175","article-title":"Mechanism of oral tolerance induction to therapeutic proteins","volume":"34","author":"Ma","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_54","first-page":"1023","article-title":"Novel gene delivery systems for periodontal tissue engineering","volume":"25","author":"Zhang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"ref_55","first-page":"303","article-title":"Saliva between normal and pathological. Important factors in determining systemic and oral health","volume":"2","author":"Iorgulescu","year":"2009","journal-title":"J. Med. Life"},{"key":"ref_56","first-page":"194","article-title":"Gene delivery to oral tissues: Challenges and therapeutic opportunities","volume":"86","author":"Kulkarni","year":"2021","journal-title":"Periodontol. 2000"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e3015","DOI":"10.1002\/jgm.3015","article-title":"Gene therapy clinical trials worldwide to 2017: An update","volume":"20","author":"Ginn","year":"2018","journal-title":"J. Gene Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"eaan4672","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/092986712803414141","article-title":"Nonviral approach for targeted nucleic acid delivery","volume":"19","author":"Jafari","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_60","unstructured":"ARM (2025, April 10). Advanced Manufacturing Strategies to Increase the Reach of Cell and Gene Therapies. Available online: https:\/\/alliancerm.org\/advanced-manufacturing-strategies\/."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric Antigen Receptor Therapy","volume":"379","author":"June","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.1158\/1078-0432.CCR-18-0758","article-title":"Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia","volume":"24","author":"Mueller","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.4049\/jimmunol.1490019","article-title":"IL-2: The first effective immunotherapy for human cancer","volume":"192","author":"Rosenberg","year":"2014","journal-title":"J. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/phar.1643","article-title":"Immune checkpoint inhibitors: New insights and current place in cancer therapy","volume":"35","author":"Jean","year":"2015","journal-title":"Pharmacotherapy"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminoncol.2014.09.004","article-title":"Mechanism of action of immunotherapy","volume":"41","author":"Disis","year":"2014","journal-title":"Semin. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1158\/1535-7163.MCT-19-0299","article-title":"Microvesicle-mediated delivery of minicircle DNA results in effective gene-directed enzyme prodrug cancer therapy","volume":"18","author":"Kanada","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.canlet.2014.12.052","article-title":"Nanoparticle delivery of HIF1\u03b1 siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer","volume":"359","author":"Chen","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/mt.2015.169","article-title":"Nanoparticle delivered VEGF-A siRNA enhances photodynamic therapy for head and neck cancer treatment","volume":"24","author":"Lecaros","year":"2016","journal-title":"Mol. Ther."},{"key":"ref_72","first-page":"139","article-title":"Advanced biomaterials and technologies for oral cancer therapy and diagnosis","volume":"31","author":"Li","year":"2024","journal-title":"Bioact. Mater."},{"key":"ref_73","first-page":"791","article-title":"Gene therapy strategies for head and neck cancer treatment","volume":"353","author":"Wang","year":"2023","journal-title":"J. Control. Release"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.trecan.2019.02.010","article-title":"YAP\/TAZ Signaling and Resistance to Cancer Therapy","volume":"5","author":"Chan","year":"2019","journal-title":"Trends Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"eaay3324","DOI":"10.1126\/sciadv.aay3324","article-title":"YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma","volume":"6","author":"Omori","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses: A new class of immunotherapy drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Chen, C.Y., Wang, P.Y., Hutzen, B., Sprague, L., Swain, H.M., Love, J.K., Stanek, J.R., Boon, L., Santiago, D.N., and Cronk, R.J. (2017). Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-02503-8"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/OV.S145532","article-title":"Oncolytic virus and PD-1\/PD-L1 blockade combination therapy","volume":"7","author":"Chen","year":"2018","journal-title":"Oncolytic Virother."},{"key":"ref_79","first-page":"209","article-title":"Emerging molecular targets for cancer pain therapy","volume":"23","author":"Schmidt","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"ref_80","unstructured":"Yang, N., Li, J., Li, J., Wei, X., Zhu, Y., Fan, S., Zhang, H., Zhang, L., Wang, Y., and Gao, Y. (2022). MicroRNAs: Pleiotropic regulators in the tumor microenvironment and their implications for HNC therapy. Front. Oncol., 12."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41578-019-0145-9","article-title":"Engineered materials for in vivo delivery of genome-editing machinery","volume":"4","author":"Tong","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"ref_82","first-page":"2435","article-title":"Oncolytic virus and PD-1\/PD-L1 blockade combination therapy for head and neck squamous cell carcinoma","volume":"72","author":"Guo","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_83","unstructured":"Liu, J., Jia, L., Hu, J., Wang, X., Liu, H., Zhu, L., Chen, Y., Zhang, H., Li, W., and Wang, Y. (2022). Radiovirotherapy: A novel strategy for the treatment of oral squamous cell carcinoma. Front. Oncol., 12."},{"key":"ref_84","first-page":"114807","article-title":"Recent progress in cancer immunotherapies combining oncolytic virotherapy and immune checkpoint inhibitors","volume":"197","author":"Tan","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_85","first-page":"20210058","article-title":"Gene therapy vectors based on nanomaterials for the treatment of oral cancer: Current status and future perspectives","volume":"3","author":"Chen","year":"2023","journal-title":"Exploration"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/gt.2009.148","article-title":"Progress and prospects: Immune responses to viral vectors","volume":"17","author":"Nayak","year":"2010","journal-title":"Gene Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5","volume":"275","author":"Bergelson","year":"1997","journal-title":"Science"},{"key":"ref_88","first-page":"2168","article-title":"Genetic implications in quality palliative care and preventing opioid crisis in cancer-related pain management","volume":"98","author":"Sumitani","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"ref_89","first-page":"1327","article-title":"Gene therapy approaches for cancer pain management","volume":"164","author":"Yang","year":"2023","journal-title":"Pain"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.tripleo.2003.12.041","article-title":"Carcinoma of the tongue: A case series analysis of clinical presentation, risk factors, staging, and outcome","volume":"98","author":"Gorsky","year":"2004","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1158\/1535-7163.MCT-11-0123","article-title":"Nerve growth factor links oral cancer progression, pain, and cachexia","volume":"10","author":"Ye","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/2051-5960-2-62","article-title":"Adenosine triphosphate drives head and neck cancer pain through P2X2\/3 heterotrimers","volume":"2","author":"Ye","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/j.pain.0000000000000099","article-title":"What pain tells us about cancer","volume":"156","author":"Schmidt","year":"2015","journal-title":"Pain"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/ACO.0b013e32833c348b","article-title":"Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): Its relevance for acute and chronic pain states","volume":"23","author":"Yarnitsky","year":"2010","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","article-title":"Central sensitization: A generator of pain hypersensitivity by central neural plasticity","volume":"10","author":"Latremoliere","year":"2009","journal-title":"J. Pain"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.tripleo.2005.10.041","article-title":"Pain complaint as the first symptom of oral cancer: A descriptive study","volume":"102","author":"Cuffari","year":"2006","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_97","first-page":"99","article-title":"Orofacial pain management: Current perspectives","volume":"7","author":"Uyanik","year":"2014","journal-title":"J. Pain Res."},{"key":"ref_98","first-page":"319","article-title":"Gene therapy approaches to pain management","volume":"5","author":"Barta","year":"2021","journal-title":"J. Transl. Genet. Genom."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejpain.2007.06.001","article-title":"Effect of peripheral endothelin-1 concentration on carcinoma-induced pain in mice","volume":"12","author":"Pickering","year":"2008","journal-title":"Eur. J. Pain"},{"key":"ref_100","first-page":"987597","article-title":"Gene therapy: A potential approach for cancer pain","volume":"2011","author":"Handy","year":"2011","journal-title":"Pain Res. Treat."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.pain.2011.06.025","article-title":"Re-expression of the methylated EDNRB gene in oral squamous cell carcinoma attenuates cancer-induced pain","volume":"152","author":"Viet","year":"2011","journal-title":"Pain"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nn.3438","article-title":"A long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons","volume":"16","author":"Zhao","year":"2013","journal-title":"Nat. Neurosci."},{"key":"ref_103","first-page":"3221","article-title":"Application of CRISPR-Cas9 to the treatment of osteoarthritis","volume":"29","author":"Collins","year":"2021","journal-title":"Mol. Ther."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ana.22446","article-title":"Gene therapy for pain: Results of a phase I clinical trial","volume":"70","author":"Fink","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1073\/pnas.94.7.3268","article-title":"Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands","volume":"94","author":"Delporte","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/gt.2015.36","article-title":"Ultrasound-assisted nonviral gene transfer of AQP1 to the irradiated minipig parotid gland restores fluid secretion","volume":"22","author":"Wang","year":"2015","journal-title":"Gene Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1089\/104303403322542257","article-title":"Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sj\u00f6gren\u2019s syndrome","volume":"14","author":"Kok","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.2005.038232","article-title":"Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sj\u00f6gren\u2019s syndrome","volume":"65","author":"Lodde","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1158\/1078-0432.CCR-10-2982","article-title":"Prevention of radiation-induced salivary hypofunction following hKGF gene delivery to murine submandibular glands","volume":"17","author":"Zheng","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Seo, Y., Shin, T.H., and Kim, H.S. (2019). Current strategies to enhance adipose stem cell function: An update. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153827"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1038\/s41467-018-06469-7","article-title":"Generation of orthotopically functional salivary gland from embryonic stem cells","volume":"9","author":"Tanaka","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/stem.2278","article-title":"Human salivary gland stem cells functionally restore radiation damaged salivary glands","volume":"34","author":"Pringle","year":"2016","journal-title":"Stem Cells"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"ref_114","first-page":"639","article-title":"A phase 1 first-in-human trial of human adipose-derived mesenchymal stromal cells in patients with radiation-induced xerostomia","volume":"113","author":"Lynggaard","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1016\/j.ijrobp.2011.11.062","article-title":"Concurrent transient activation of Wnt\/\u03b2-catenin pathway prevents radiation damage to salivary glands","volume":"83","author":"Hai","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s40544-021-0586-1","article-title":"Unlocking the secrets behind liquid superlubricity: A state-of-the-art review on phenomena and mechanisms","volume":"10","author":"Han","year":"2022","journal-title":"Friction"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Austin, W., Hdeib, M., Fraser, P., Goldchtaub, M., Shams, E., Han, T., Zhang, S., Saad, A., Kaur, K., and Haran, N. (2024). Oral Lubrication, Xerostomia, and Advanced Macromolecular Lubricants for Treatment of Dry Mouth. Lubricants, 12.","DOI":"10.3390\/lubricants12040126"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/gt.2008.174","article-title":"AAV2\/1-TNFR gene delivery prevents periodontal disease progression","volume":"16","author":"Cirelli","year":"2009","journal-title":"Gene Ther."},{"key":"ref_119","first-page":"1089","article-title":"Gene therapy in periodontal regeneration: Current status and future perspectives","volume":"102","author":"Jin","year":"2023","journal-title":"J. Dent. Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/ten.tea.2022.0162","article-title":"Regenerative potential of bone morphogenetic protein 7-engineered mesenchymal stem cells in ligature-induced periodontitis","volume":"29","author":"Jung","year":"2023","journal-title":"Tissue Eng. Part A"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e23501","DOI":"10.1002\/dvg.23501","article-title":"Advanced biomaterials for periodontal tissue regeneration","volume":"60","author":"Daghrery","year":"2022","journal-title":"Genesis"},{"key":"ref_122","first-page":"195","article-title":"Computational perspectives of cellular gene regulatory networks with multiplexed single-cell data","volume":"3","author":"Dang","year":"2020","journal-title":"Annu. Rev. Biomed. Data Sci."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Theodoridis, K., Arampatzis, A.S., Liasi, G., Tsalikis, L., Barmpalexis, P., Christofilos, D., Chatzinikolaidou, M., and Fatouros, D.G. (2023). Development of an interpenetrating network of chitosan\/gelatin hybrid hydrogel incorporating plicalocenol. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242316754"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/odi.14692","article-title":"Recent progress in regenerative therapy for damaged salivary glands: From bench to bedside","volume":"30","author":"Ito","year":"2024","journal-title":"Oral Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12967-021-03125-5","article-title":"Advances in mesenchymal stem cell conditioned medium-mediated periodontal tissue regeneration","volume":"19","author":"Lin","year":"2021","journal-title":"J. Transl. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"7564689","DOI":"10.1155\/2016\/7564689","article-title":"Three-dimensional bioprinting nanotechnologies towards clinical application of stem cells","volume":"2016","author":"Ferreira","year":"2016","journal-title":"Stem Cells Int."},{"key":"ref_127","first-page":"100016","article-title":"The application of artificial intelligence in oral gene therapy: Challenges and opportunities","volume":"2","author":"Yang","year":"2023","journal-title":"Innov. Life"},{"key":"ref_128","unstructured":"Marsden, G., Towse, A., Pearson, S.D., Dreitlein, B., and Henshall, C. (2017). Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value, ICER."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/bmj.330.7482.79","article-title":"Recent developments in gene transfer: Risk and ethics","volume":"330","author":"Kimmelman","year":"2005","journal-title":"BMJ"},{"key":"ref_131","first-page":"12","article-title":"The Xerostomia Inventory: A multi-item approach to measuring dry mouth","volume":"28","author":"Thomson","year":"2011","journal-title":"Community Dent. Health"},{"key":"ref_132","first-page":"129","article-title":"Pain assessment: Global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann. Acad. Med. Singapore"},{"key":"ref_133","first-page":"3","article-title":"Development and evaluation of the Oral Health Impact Profile","volume":"11","author":"Slade","year":"1994","journal-title":"Community Dent. Health"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ajhg.2017.06.012","article-title":"Human germline genome editing","volume":"101","author":"Ormond","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature15818","article-title":"Gene therapy returns to centre stage","volume":"526","author":"Naldini","year":"2015","journal-title":"Nature"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Abughanam, G., Elkashty, O.A., Liu, Y., Bakkar, M.O., and Tran, S.D. (2019). Mesenchymal stem cells extract (MSCsE)-based therapy alleviates xerostomia and keratoconjunctivitis sicca in Sjogren\u2019s syndrome-like disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20194750"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/cpt.3087","article-title":"Practical and Statistical Considerations for the Long Term Follow-Up of Gene Therapy Trial Participants","volume":"115","author":"Rohde","year":"2024","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/7\/859\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:02:17Z","timestamp":1760032937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/7\/859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":137,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["pharmaceutics17070859"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics17070859","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]}}}